Global Neurological Biomarkers Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Global Neurological Biomarkers Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Table of Contents
1 Study Coverage
1.1 Neurological Biomarkers Product Introduction
1.2 Market by Type
1.2.1 Global Neurological Biomarkers Market Size Growth Rate by Type
1.2.2 Proteomics
1.2.3 Genomics
1.2.4 Imaging
1.2.5 Bioinformatics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neurological Biomarkers Market Size Growth Rate by Application
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Neurological Biomarkers Market Size Estimates and Forecasts
2.1.1 Global Neurological Biomarkers Revenue 2016-2027
2.1.2 Global Neurological Biomarkers Sales 2016-2027
2.2 Neurological Biomarkers Market Size by Region: 2021 Versus 2027
2.3 Neurological Biomarkers Sales by Region (2016-2027)
2.3.1 Global Neurological Biomarkers Sales by Region: 2016-2021
2.3.2 Global Neurological Biomarkers Sales Forecast by Region (2022-2027)
2.3.3 Global Neurological Biomarkers Sales Market Share by Region (2016-2027)
2.4 Neurological Biomarkers Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Neurological Biomarkers Revenue by Region: 2016-2021
2.4.2 Global Neurological Biomarkers Revenue Forecast by Region (2022-2027)
2.4.3 Global Neurological Biomarkers Revenue Market Share by Region (2016-2027)
3 Global Neurological Biomarkers by Manufacturers
3.1 Global Top Neurological Biomarkers Manufacturers by Sales
3.1.1 Global Neurological Biomarkers Sales by Manufacturer (2016-2021)
3.1.2 Global Neurological Biomarkers Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Neurological Biomarkers Manufacturers by Revenue
3.2.1 Global Neurological Biomarkers Revenue by Manufacturer (2016-2021)
3.2.2 Global Neurological Biomarkers Revenue Share by Manufacturer (2016-2021)
3.3 Global Neurological Biomarkers Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Neurological Biomarkers Manufacturers Covered: Ranking by Revenue
3.4.2 Global Neurological Biomarkers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Neurological Biomarkers Manufacturing Base Distribution, Product Type
3.5.1 Neurological Biomarkers Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Neurological Biomarkers Product Type
3.5.3 Date of International Manufacturers Enter into Neurological Biomarkers Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Thermo Fisher Scientific
4.1.1 Thermo Fisher Scientific Corporation Information
4.1.2 Thermo Fisher Scientific Description, Business Overview
4.1.3 Thermo Fisher Scientific Neurological Biomarkers Products Offered
4.1.4 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Thermo Fisher Scientific Neurological Biomarkers Revenue by Product
4.1.6 Thermo Fisher Scientific Neurological Biomarkers Revenue by Application
4.1.7 Thermo Fisher Scientific Neurological Biomarkers Revenue by Geographic Area
4.1.8 Thermo Fisher Scientific Neurological Biomarkers Revenue by Sales Channel
4.1.9 Thermo Fisher Scientific Recent Development
4.2 Merck
4.2.1 Merck Corporation Information
4.2.2 Merck Description, Business Overview
4.2.3 Merck Neurological Biomarkers Products Offered
4.2.4 Merck Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Merck Neurological Biomarkers Revenue by Product
4.2.6 Merck Neurological Biomarkers Revenue by Application
4.2.7 Merck Neurological Biomarkers Revenue by Geographic Area
4.2.8 Merck Neurological Biomarkers Revenue by Sales Channel
4.2.9 Merck Recent Development
4.3 Quest Diagnostics
4.3.1 Quest Diagnostics Corporation Information
4.3.2 Quest Diagnostics Description, Business Overview
4.3.3 Quest Diagnostics Neurological Biomarkers Products Offered
4.3.4 Quest Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Quest Diagnostics Neurological Biomarkers Revenue by Product
4.3.6 Quest Diagnostics Neurological Biomarkers Revenue by Application
4.3.7 Quest Diagnostics Neurological Biomarkers Revenue by Geographic Area
4.3.8 Quest Diagnostics Neurological Biomarkers Revenue by Sales Channel
4.3.9 Quest Diagnostics Recent Development
4.4 Abbott
4.4.1 Abbott Corporation Information
4.4.2 Abbott Description, Business Overview
4.4.3 Abbott Neurological Biomarkers Products Offered
4.4.4 Abbott Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Abbott Neurological Biomarkers Revenue by Product
4.4.6 Abbott Neurological Biomarkers Revenue by Application
4.4.7 Abbott Neurological Biomarkers Revenue by Geographic Area
4.4.8 Abbott Neurological Biomarkers Revenue by Sales Channel
4.4.9 Abbott Recent Development
4.5 Roche
4.5.1 Roche Corporation Information
4.5.2 Roche Description, Business Overview
4.5.3 Roche Neurological Biomarkers Products Offered
4.5.4 Roche Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Roche Neurological Biomarkers Revenue by Product
4.5.6 Roche Neurological Biomarkers Revenue by Application
4.5.7 Roche Neurological Biomarkers Revenue by Geographic Area
4.5.8 Roche Neurological Biomarkers Revenue by Sales Channel
4.5.9 Roche Recent Development
4.6 Illumina
4.6.1 Illumina Corporation Information
4.6.2 Illumina Description, Business Overview
4.6.3 Illumina Neurological Biomarkers Products Offered
4.6.4 Illumina Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Illumina Neurological Biomarkers Revenue by Product
4.6.6 Illumina Neurological Biomarkers Revenue by Application
4.6.7 Illumina Neurological Biomarkers Revenue by Geographic Area
4.6.8 Illumina Recent Development
4.7 Bio-Rad Laboratories
4.7.1 Bio-Rad Laboratories Corporation Information
4.7.2 Bio-Rad Laboratories Description, Business Overview
4.7.3 Bio-Rad Laboratories Neurological Biomarkers Products Offered
4.7.4 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
4.7.5 Bio-Rad Laboratories Neurological Biomarkers Revenue by Product
4.7.6 Bio-Rad Laboratories Neurological Biomarkers Revenue by Application
4.7.7 Bio-Rad Laboratories Neurological Biomarkers Revenue by Geographic Area
4.7.8 Bio-Rad Laboratories Recent Development
4.8 QIAGEN
4.8.1 QIAGEN Corporation Information
4.8.2 QIAGEN Description, Business Overview
4.8.3 QIAGEN Neurological Biomarkers Products Offered
4.8.4 QIAGEN Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
4.8.5 QIAGEN Neurological Biomarkers Revenue by Product
4.8.6 QIAGEN Neurological Biomarkers Revenue by Application
4.8.7 QIAGEN Neurological Biomarkers Revenue by Geographic Area
4.8.8 QIAGEN Recent Development
4.9 Myriad RBM
4.9.1 Myriad RBM Corporation Information
4.9.2 Myriad RBM Description, Business Overview
4.9.3 Myriad RBM Neurological Biomarkers Products Offered
4.9.4 Myriad RBM Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
4.9.5 Myriad RBM Neurological Biomarkers Revenue by Product
4.9.6 Myriad RBM Neurological Biomarkers Revenue by Application
4.9.7 Myriad RBM Neurological Biomarkers Revenue by Geographic Area
4.9.8 Myriad RBM Recent Development
4.10 Cisbio Bioassays
4.10.1 Cisbio Bioassays Corporation Information
4.10.2 Cisbio Bioassays Description, Business Overview
4.10.3 Cisbio Bioassays Neurological Biomarkers Products Offered
4.10.4 Cisbio Bioassays Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
4.10.5 Cisbio Bioassays Neurological Biomarkers Revenue by Product
4.10.6 Cisbio Bioassays Neurological Biomarkers Revenue by Application
4.10.7 Cisbio Bioassays Neurological Biomarkers Revenue by Geographic Area
4.10.8 Cisbio Bioassays Recent Development
4.11 Athena Diagnostics
4.11.1 Athena Diagnostics Corporation Information
4.11.2 Athena Diagnostics Description, Business Overview
4.11.3 Athena Diagnostics Neurological Biomarkers Products Offered
4.11.4 Athena Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
4.11.5 Athena Diagnostics Neurological Biomarkers Revenue by Product
4.11.6 Athena Diagnostics Neurological Biomarkers Revenue by Application
4.11.7 Athena Diagnostics Neurological Biomarkers Revenue by Geographic Area
4.11.8 Athena Diagnostics Recent Development
4.12 BGI
4.12.1 BGI Corporation Information
4.12.2 BGI Description, Business Overview
4.12.3 BGI Neurological Biomarkers Products Offered
4.12.4 BGI Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
4.12.5 BGI Neurological Biomarkers Revenue by Product
4.12.6 BGI Neurological Biomarkers Revenue by Application
4.12.7 BGI Neurological Biomarkers Revenue by Geographic Area
4.12.8 BGI Recent Development
4.13 Wuxi APP
4.13.1 Wuxi APP Corporation Information
4.13.2 Wuxi APP Description, Business Overview
4.13.3 Wuxi APP Neurological Biomarkers Products Offered
4.13.4 Wuxi APP Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
4.13.5 Wuxi APP Neurological Biomarkers Revenue by Product
4.13.6 Wuxi APP Neurological Biomarkers Revenue by Application
4.13.7 Wuxi APP Neurological Biomarkers Revenue by Geographic Area
4.13.8 Wuxi APP Recent Development
4.14 Aepodia
4.14.1 Aepodia Corporation Information
4.14.2 Aepodia Description, Business Overview
4.14.3 Aepodia Neurological Biomarkers Products Offered
4.14.4 Aepodia Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
4.14.5 Aepodia Neurological Biomarkers Revenue by Product
4.14.6 Aepodia Neurological Biomarkers Revenue by Application
4.14.7 Aepodia Neurological Biomarkers Revenue by Geographic Area
4.14.8 Aepodia Recent Development
4.15 Proteome Sciences
4.15.1 Proteome Sciences Corporation Information
4.15.2 Proteome Sciences Description, Business Overview
4.15.3 Proteome Sciences Neurological Biomarkers Products Offered
4.15.4 Proteome Sciences Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
4.15.5 Proteome Sciences Neurological Biomarkers Revenue by Product
4.15.6 Proteome Sciences Neurological Biomarkers Revenue by Application
4.15.7 Proteome Sciences Neurological Biomarkers Revenue by Geographic Area
4.15.8 Proteome Sciences Recent Development
4.16 Genewiz
4.16.1 Genewiz Corporation Information
4.16.2 Genewiz Description, Business Overview
4.16.3 Genewiz Neurological Biomarkers Products Offered
4.16.4 Genewiz Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
4.16.5 Genewiz Neurological Biomarkers Revenue by Product
4.16.6 Genewiz Neurological Biomarkers Revenue by Application
4.16.7 Genewiz Neurological Biomarkers Revenue by Geographic Area
4.16.8 Genewiz Recent Development
5 Breakdown Data by Type
5.1 Global Neurological Biomarkers Sales by Type (2016-2027)
5.1.1 Global Neurological Biomarkers Sales by Type (2016-2021)
5.1.2 Global Neurological Biomarkers Sales Forecast by Type (2022-2027)
5.1.3 Global Neurological Biomarkers Sales Market Share by Type (2016-2027)
5.2 Global Neurological Biomarkers Revenue Forecast by Type (2016-2027)
5.2.1 Global Neurological Biomarkers Revenue by Type (2016-2021)
5.2.2 Global Neurological Biomarkers Revenue Forecast by Type (2022-2027)
5.2.3 Global Neurological Biomarkers Revenue Market Share by Type (2016-2027)
5.3 Neurological Biomarkers Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Neurological Biomarkers Sales by Application (2016-2027)
6.1.1 Global Neurological Biomarkers Sales by Application (2016-2021)
6.1.2 Global Neurological Biomarkers Sales Forecast by Application (2022-2027)
6.1.3 Global Neurological Biomarkers Sales Market Share by Application (2016-2027)
6.2 Global Neurological Biomarkers Revenue Forecast by Application (2016-2027)
6.2.1 Global Neurological Biomarkers Revenue by Application (2016-2021)
6.2.2 Global Neurological Biomarkers Revenue Forecast by Application (2022-2027)
6.2.3 Global Neurological Biomarkers Revenue Market Share by Application (2016-2027)
6.3 Neurological Biomarkers Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Neurological Biomarkers Market Size YoY Growth 2016-2027
7.2 North America Neurological Biomarkers Market Facts & Figures by Country
7.2.1 North America Neurological Biomarkers Sales by Country (2016-2027)
7.2.2 North America Neurological Biomarkers Revenue by Country (2016-2027)
7.3 North America Neurological Biomarkers Sales by Type
7.4 North America Neurological Biomarkers Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Neurological Biomarkers Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Neurological Biomarkers Market Facts & Figures by Region
8.2.1 Asia-Pacific Neurological Biomarkers Sales by Region (2016-2027)
8.2.2 Asia-Pacific Neurological Biomarkers Revenue by Region (2016-2027)
8.3 Asia-Pacific Neurological Biomarkers Sales by Type
8.4 Asia-Pacific Neurological Biomarkers Sales by Application
9 Europe
9.1 Europe Neurological Biomarkers Market Size YoY Growth 2016-2027
9.2 Europe Neurological Biomarkers Market Facts & Figures by Country
9.2.1 Europe Neurological Biomarkers Sales by Country (2016-2027)
9.2.2 Europe Neurological Biomarkers Revenue by Country (2016-2027)
9.3 Europe Neurological Biomarkers Sales by Type
9.4 Europe Neurological Biomarkers Sales by Application
10 Latin America
10.1 Latin America Neurological Biomarkers Market Size YoY Growth 2016-2027
10.2 Latin America Neurological Biomarkers Market Facts & Figures by Country
10.2.1 Latin America Neurological Biomarkers Sales by Country (2016-2027)
10.2.2 Latin America Neurological Biomarkers Revenue by Country (2016-2027)
10.3 Latin America Neurological Biomarkers Sales by Type
10.4 Latin America Neurological Biomarkers Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Neurological Biomarkers Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Neurological Biomarkers Market Facts & Figures by Country
11.2.1 Middle East and Africa Neurological Biomarkers Sales by Country (2016-2027)
11.2.2 Middle East and Africa Neurological Biomarkers Revenue by Country (2016-2027)
11.3 Middle East and Africa Neurological Biomarkers Sales by Type
11.4 Middle East and Africa Neurological Biomarkers Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Neurological Biomarkers Supply Chain Analysis
12.2 Neurological Biomarkers Key Raw Materials and Upstream Suppliers
12.3 Neurological Biomarkers Clients Analysis
12.4 Neurological Biomarkers Sales Channel and Sales Model Analysis
12.4.1 Neurological Biomarkers Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Neurological Biomarkers Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Neurological Biomarkers Distributors
13 Market Dynamics
13.1 Neurological Biomarkers Market Drivers
13.2 Neurological Biomarkers Market Opportunities
13.3 Neurological Biomarkers Market Challenges
13.4 Neurological Biomarkers Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Neurological Biomarkers Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Major Manufacturers of Proteomics
Table 3. Major Manufacturers of Genomics
Table 4. Major Manufacturers of Imaging
Table 5. Major Manufacturers of Bioinformatics
Table 6. Major Manufacturers of Others
Table 7. Global Neurological Biomarkers Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 8. Global Neurological Biomarkers Market Size by Region (US$ Million): 2021 VS 2027
Table 9. Global Neurological Biomarkers Sales by Region (2016-2021) & (K Units)
Table 10. Global Neurological Biomarkers Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Neurological Biomarkers Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Neurological Biomarkers Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Neurological Biomarkers Sales by Manufacturer (2016-2021) & (K Units)
Table 14. Global Neurological Biomarkers Sales Share by Manufacturer (2016-2021)
Table 15. Neurological Biomarkers Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 16. Neurological Biomarkers Revenue Share by Manufacturer (2016-2021)
Table 17. Key Manufacturers Neurological Biomarkers Price (2016-2021) & (USD/Unit)
Table 18. Ranking of Global Top Neurological Biomarkers Manufacturers by Revenue (US$ Million) in 2020
Table 19. Global Neurological Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Neurological Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurological Biomarkers as of 2020)
Table 21. Neurological Biomarkers Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Neurological Biomarkers Product Type
Table 23. Date of International Manufacturers Enter into Neurological Biomarkers Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Thermo Fisher Scientific Corporation Information
Table 26. Thermo Fisher Scientific Description and Business Overview
Table 27. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 28. Thermo Fisher Scientific Neurological Biomarkers Product
Table 29. Thermo Fisher Scientific Neurological Biomarkers Revenue (US$ Million) and Market Share by Product
Table 30. Thermo Fisher Scientific Neurological Biomarkers Revenue (US$ Million) and Market Share by Application
Table 31. Thermo Fisher Scientific Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area
Table 32. Thermo Fisher Scientific Neurological Biomarkers Revenue (US$ Million) and Market Share by Sales Channel
Table 33. Thermo Fisher Scientific Recent Development
Table 34. Merck Corporation Information
Table 35. Merck Description and Business Overview
Table 36. Merck Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 37. Merck Neurological Biomarkers Product
Table 38. Merck Neurological Biomarkers Revenue (US$ Million) and Market Share by Product
Table 39. Merck Neurological Biomarkers Revenue (US$ Million) and Market Share by Application
Table 40. Merck Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area
Table 41. Merck Neurological Biomarkers Revenue (US$ Million) and Market Share by Sales Channel
Table 42. Merck Recent Development
Table 43. Quest Diagnostics Corporation Information
Table 44. Quest Diagnostics Description and Business Overview
Table 45. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 46. Quest Diagnostics Neurological Biomarkers Product
Table 47. Quest Diagnostics Neurological Biomarkers Revenue (US$ Million) and Market Share by Product
Table 48. Quest Diagnostics Neurological Biomarkers Revenue (US$ Million) and Market Share by Application
Table 49. Quest Diagnostics Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area
Table 50. Quest Diagnostics Neurological Biomarkers Revenue (US$ Million) and Market Share by Sales Channel
Table 51. Quest Diagnostics Recent Development
Table 52. Abbott Corporation Information
Table 53. Abbott Description and Business Overview
Table 54. Abbott Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 55. Abbott Neurological Biomarkers Product
Table 56. Abbott Neurological Biomarkers Revenue (US$ Million) and Market Share by Product
Table 57. Abbott Neurological Biomarkers Revenue (US$ Million) and Market Share by Application
Table 58. Abbott Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area
Table 59. Abbott Neurological Biomarkers Revenue (US$ Million) and Market Share by Sales Channel
Table 60. Abbott Recent Development
Table 61. Roche Corporation Information
Table 62. Roche Description and Business Overview
Table 63. Roche Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 64. Roche Neurological Biomarkers Product
Table 65. Roche Neurological Biomarkers Revenue (US$ Million) and Market Share by Product
Table 66. Roche Neurological Biomarkers Revenue (US$ Million) and Market Share by Application
Table 67. Roche Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area
Table 68. Roche Neurological Biomarkers Revenue (US$ Million) and Market Share by Sales Channel
Table 69. Roche Recent Development
Table 70. Illumina Corporation Information
Table 71. Illumina Description and Business Overview
Table 72. Illumina Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 73. Illumina Neurological Biomarkers Product
Table 74. Illumina Neurological Biomarkers Revenue (US$ Million) and Market Share by Product
Table 75. Illumina Neurological Biomarkers Revenue (US$ Million) and Market Share by Application
Table 76. Illumina Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area
Table 77. Illumina Recent Development
Table 78. Bio-Rad Laboratories Corporation Information
Table 79. Bio-Rad Laboratories Description and Business Overview
Table 80. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Bio-Rad Laboratories Neurological Biomarkers Product
Table 82. Bio-Rad Laboratories Neurological Biomarkers Revenue (US$ Million) and Market Share by Product
Table 83. Bio-Rad Laboratories Neurological Biomarkers Revenue (US$ Million) and Market Share by Application
Table 84. Bio-Rad Laboratories Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area
Table 85. Bio-Rad Laboratories Recent Development
Table 86. QIAGEN Corporation Information
Table 87. QIAGEN Description and Business Overview
Table 88. QIAGEN Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 89. QIAGEN Neurological Biomarkers Product
Table 90. QIAGEN Neurological Biomarkers Revenue (US$ Million) and Market Share by Product
Table 91. QIAGEN Neurological Biomarkers Revenue (US$ Million) and Market Share by Application
Table 92. QIAGEN Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area
Table 93. QIAGEN Recent Development
Table 94. Myriad RBM Corporation Information
Table 95. Myriad RBM Description and Business Overview
Table 96. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 97. Myriad RBM Neurological Biomarkers Product
Table 98. Myriad RBM Neurological Biomarkers Revenue (US$ Million) and Market Share by Product
Table 99. Myriad RBM Neurological Biomarkers Revenue (US$ Million) and Market Share by Application
Table 100. Myriad RBM Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area
Table 101. Myriad RBM Recent Development
Table 102. Cisbio Bioassays Corporation Information
Table 103. Cisbio Bioassays Description and Business Overview
Table 104. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. Cisbio Bioassays Neurological Biomarkers Product
Table 106. Cisbio Bioassays Neurological Biomarkers Revenue (US$ Million) and Market Share by Product
Table 107. Cisbio Bioassays Neurological Biomarkers Revenue (US$ Million) and Market Share by Application
Table 108. Cisbio Bioassays Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area
Table 109. Cisbio Bioassays Recent Development
Table 110. Athena Diagnostics Corporation Information
Table 111. Athena Diagnostics Description and Business Overview
Table 112. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Athena Diagnostics Neurological Biomarkers Product
Table 114. Athena Diagnostics Neurological Biomarkers Revenue (US$ Million) and Market Share by Product
Table 115. Athena Diagnostics Neurological Biomarkers Revenue (US$ Million) and Market Share by Application
Table 116. Athena Diagnostics Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area
Table 117. Athena Diagnostics Recent Development
Table 118. BGI Corporation Information
Table 119. BGI Description and Business Overview
Table 120. BGI Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. BGI Neurological Biomarkers Product
Table 122. BGI Neurological Biomarkers Revenue (US$ Million) and Market Share by Product
Table 123. BGI Neurological Biomarkers Revenue (US$ Million) and Market Share by Application
Table 124. BGI Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area
Table 125. BGI Recent Development
Table 126. Wuxi APP Corporation Information
Table 127. Wuxi APP Description and Business Overview
Table 128. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 129. Wuxi APP Neurological Biomarkers Product
Table 130. Wuxi APP Neurological Biomarkers Revenue (US$ Million) and Market Share by Product
Table 131. Wuxi APP Neurological Biomarkers Revenue (US$ Million) and Market Share by Application
Table 132. Wuxi APP Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area
Table 133. Wuxi APP Recent Development
Table 134. Aepodia Corporation Information
Table 135. Aepodia Description and Business Overview
Table 136. Aepodia Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 137. Aepodia Neurological Biomarkers Product
Table 138. Aepodia Neurological Biomarkers Revenue (US$ Million) and Market Share by Product
Table 139. Aepodia Neurological Biomarkers Revenue (US$ Million) and Market Share by Application
Table 140. Aepodia Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area
Table 141. Aepodia Recent Development
Table 142. Proteome Sciences Corporation Information
Table 143. Proteome Sciences Description and Business Overview
Table 144. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 145. Proteome Sciences Neurological Biomarkers Product
Table 146. Proteome Sciences Neurological Biomarkers Revenue (US$ Million) and Market Share by Product
Table 147. Proteome Sciences Neurological Biomarkers Revenue (US$ Million) and Market Share by Application
Table 148. Proteome Sciences Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area
Table 149. Proteome Sciences Recent Development
Table 150. Genewiz Corporation Information
Table 151. Genewiz Description and Business Overview
Table 152. Genewiz Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 153. Genewiz Neurological Biomarkers Product
Table 154. Genewiz Neurological Biomarkers Revenue (US$ Million) and Market Share by Product
Table 155. Genewiz Neurological Biomarkers Revenue (US$ Million) and Market Share by Application
Table 156. Genewiz Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area
Table 157. Genewiz Recent Development
Table 158. Global Neurological Biomarkers Sales by Type (2016-2021) & (K Units)
Table 159. Global Neurological Biomarkers Sales Forecast by Type (2022-2027) & (K Units)
Table 160. Global Neurological Biomarkers Revenue by Type (2016-2021) & (US$ Million)
Table 161. Global Neurological Biomarkers Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 162. Global Neurological Biomarkers Sales by Application (2016-2021) & (K Units)
Table 163. Global Neurological Biomarkers Sales Forecast by Application (2022-2027) & (K Units)
Table 164. Global Neurological Biomarkers Revenue by Application (2016-2021) & (US$ Million)
Table 165. Global Neurological Biomarkers Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 166. North America Neurological Biomarkers Sales by Country (2016-2021) & (K Units)
Table 167. North America Neurological Biomarkers Sales by Country (2022-2027) & (K Units)
Table 168. North America Neurological Biomarkers Revenue by Country (2016-2021) & (US$ Million)
Table 169. North America Neurological Biomarkers Revenue by Country (2022-2027) & (US$ Million)
Table 170. North America Neurological Biomarkers Sales by Type (2016-2021) & (K Units)
Table 171. North America Neurological Biomarkers Sales by Application (2016-2021) & (K Units)
Table 172. Asia-Pacific Neurological Biomarkers Sales by Region (2016-2021) & (K Units)
Table 173. Asia-Pacific Neurological Biomarkers Sales by Region (2022-2027) & (K Units)
Table 174. Asia-Pacific Neurological Biomarkers Revenue by Region (2016-2027) & (US$ Million)
Table 175. Asia-Pacific Neurological Biomarkers Revenue by Region (2022-2027) & (US$ Million)
Table 176. Asia-Pacific Neurological Biomarkers Sales by Type (2016-2021) & (K Units)
Table 177. Asia-Pacific Neurological Biomarkers Sales by Application (2016-2021) & (K Units)
Table 178. Europe Neurological Biomarkers Sales by Country (2016-2021) & (K Units)
Table 179. Europe Neurological Biomarkers Sales by Country (2022-2027) & (K Uni

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs